Having your say
We seek the views of all people who have an interest in our proposals, or who may be affected by them, to obtain feedback on our proposed approaches.
You can respond to a consultation by writing to the address in the consultation letter.
We are not able to treat any part of your feedback as confidential unless you specifically request that we do. If you would like us to withhold any commercially sensitive, confidential proprietary, or personal information included in your submission, please clearly state this in your submission and identify the relevant sections of your submission that you would like withheld.
Feedback we receive is subject to the Official Information Act 1982 (OIA) and we will consider any request to have information withheld in accordance with our obligations under the OIA.
26 March 2013 PHARMAC is seeking feedback on a proposal to fund the antiplatelet agent ticagrelor (Brilinta). Closed: Friday, 12 April 2013.
12 March 2013 Closed: 5 April 2013.
11 March 2013 Closed.
25 February 2013 Closed.
Proposals to list glyceryl trinitrate ointment (Rectogesic) for chronic anal fissure and to apply reference pricing across brands of lignocaine 1% injections
12 February 2013 Closed.
30 January 2013 Closed.
20 January 2013 Closed: Tuesday, 12 February 2012
14 January 2013 PHARMAC has entered into a provisional agreement for the funding and supply of 11 pharmaceuticals that do not have Medsafe consent (i.e. are not approved/registered). Closed: Friday, 1 February 2013.
10 December 2012 Closed: Friday, 21 December 2012.
Last updated: 19 August 2016